In addition, an animal experiment discloses that anti-PTGS2 inhibitor has been observed to improve cognitive decline of AD via concurrently inducing neurogenesis and reducing apoptosis in transgenic mice (Guo et al., 2017). Here, PTGS2 is linked to Alzheimer disease.